The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N05 | Psycholeptics | |
| 3 | N05A | Antipsychotics | |
| 4 | N05AD | Butyrophenone derivatives |
| Code | Title | |
|---|---|---|
| N05AD01 | Haloperidol | |
| N05AD02 | Trifluperidol | |
| N05AD03 | Melperone | |
| N05AD04 | Moperone | |
| N05AD05 | Pipamperone | |
| N05AD06 | Bromperidol | |
| N05AD07 | Benperidol | |
| N05AD08 | Droperidol | |
| N05AD09 | Fluanisone | |
| N05AD10 |
| Active Ingredient | Description | |
|---|---|---|
| Benperidol |
Benperidol is a strong dopamine receptor antagonist with weaker serotonin receptor antagonism. In high doses, it has antihistaminergic and alpha-adrenergic properties. It possesses minimal anticholinergic properties. Benperidol is a typical antipsychotic primarily used to treat hypersexuality syndromes and can be used to treat schizophrenia. |
|
| Bromperidol |
|
|
| Droperidol |
Droperidol is a butyrophenone neuroleptic. Its pharmacologic profile is characterised mainly by dopamine-blocking and weak α1-adrenolytic effects. Droperidol is devoid of anticholinergic and antihistaminic activity. |
|
| Haloperidol |
Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. |
|
| Melperone |
|
|
| Pipamperone |
|
|
| Spiperone |
|
|
| Timiperone |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| ANQUIL Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| HALDOL DECANOATE Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| HALOXEN Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| SERENACE Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| XOMOLIX Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
